These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7303288

  • 1. [Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
    Bøttcher J, Grøn U.
    Ugeskr Laeger; 1981 Oct 05; 143(41):2648-9. PubMed ID: 7303288
    [No Abstract] [Full Text] [Related]

  • 2. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
    Douvier JJ, Vergeret J, Taytard A, Brottier E, Domblides P, Dubos F, Freour P.
    Ann Med Interne (Paris); 1985 Oct 05; 136(5):416-8. PubMed ID: 4062141
    [Abstract] [Full Text] [Related]

  • 3. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
    McElvaney NG, Wilcox PG, Churg A, Fleetham JA.
    Arch Intern Med; 1988 Oct 05; 148(10):2231-6. PubMed ID: 3178380
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC, Mendoza MM, Yahr MD.
    Adv Biochem Psychopharmacol; 1980 Oct 05; 23():271-5. PubMed ID: 7395618
    [No Abstract] [Full Text] [Related]

  • 5. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
    Godwin-Austen RB.
    Adv Biochem Psychopharmacol; 1980 Oct 05; 23():261-5. PubMed ID: 7395616
    [No Abstract] [Full Text] [Related]

  • 6. [Bromocriptine-induced pleuropneumopathy].
    Schmid PA, Suter T, Speich R, Eberli F, Greminger P.
    Dtsch Med Wochenschr; 1994 Nov 11; 119(45):1543-6. PubMed ID: 7956789
    [Abstract] [Full Text] [Related]

  • 7. Pleuropulmonary disease associated with dopamine agonist therapy.
    Bhatt MH, Keenan SP, Fleetham JA, Calne DB.
    Ann Neurol; 1991 Oct 11; 30(4):613-6. PubMed ID: 1686385
    [Abstract] [Full Text] [Related]

  • 8. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM, Lees AJ, Shaw KM, Lander CM.
    Adv Biochem Psychopharmacol; 1980 Oct 11; 23():267-70. PubMed ID: 7395617
    [No Abstract] [Full Text] [Related]

  • 9. [Pleural effusion induced by bromocriptine].
    Diot E, Diot P, Le Rolland A, Jonville AP, Lasfargues G, Lemarie E, Lavandier M, Guilmot JL.
    Rev Mal Respir; 1990 Oct 11; 7(2):175-7. PubMed ID: 2320790
    [Abstract] [Full Text] [Related]

  • 10. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL, Schmitt L, Bagheri H.
    Rev Neurol (Paris); 2003 Apr 11; 159(4):441-3. PubMed ID: 12773874
    [Abstract] [Full Text] [Related]

  • 11. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
    de Yébenes JG, García-Ruiz PJ, Sánchez-Pernaute R.
    Rev Neurol; 1997 Sep 11; 25(145):1343-5. PubMed ID: 9377286
    [Abstract] [Full Text] [Related]

  • 12. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan 11; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 13. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW.
    Mov Disord; 2000 May 11; 15(3):485-9. PubMed ID: 10830413
    [Abstract] [Full Text] [Related]

  • 14. Pleuropulmonary involvement during bromocriptine treatment.
    Kinnunen E, Viljanen A.
    Chest; 1988 Nov 11; 94(5):1034-6. PubMed ID: 3180854
    [Abstract] [Full Text] [Related]

  • 15. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
    Factor SA, Weiner WJ.
    Mov Disord; 1993 Jul 11; 8(3):257-62. PubMed ID: 8341289
    [Abstract] [Full Text] [Related]

  • 16. [Pleuropulmonary changes during treatment with bromocriptine].
    Ugeskr Laeger; 1988 May 02; 150(18):1124. PubMed ID: 3368987
    [No Abstract] [Full Text] [Related]

  • 17. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
    Pezzoli G, Martignoni E, Pacchetti C, Angeleri VA, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E.
    Mov Disord; 1994 Jul 02; 9(4):431-6. PubMed ID: 7969210
    [Abstract] [Full Text] [Related]

  • 18. Pleuropulmonary reactions in patients on bromocriptine treatment.
    Tornling G, Unge G, Axelsson G, Noring L, Granerus AK.
    Eur J Respir Dis; 1986 Jan 02; 68(1):35-8. PubMed ID: 3948932
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC, Chew EL, Ong YY.
    Singapore Med J; 2001 Feb 02; 42(2):85-8. PubMed ID: 11358199
    [Abstract] [Full Text] [Related]

  • 20. Further experiences with low doses of bromocriptine in Parkinson's disease.
    Fahn S, Côté LJ, Barrett RE, Snider SR.
    Adv Biochem Psychopharmacol; 1980 Feb 02; 23():255-60. PubMed ID: 7395615
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.